Compare ELOX & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ELOX | MOBX |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.0M | 33.5M |
| IPO Year | 2013 | 2021 |
| Metric | ELOX | MOBX |
|---|---|---|
| Price | $15.75 | $1.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.6K | ★ 6.9M |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,442,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 426.31 |
| 52 Week Low | $10.00 | $0.13 |
| 52 Week High | $23.40 | $4.25 |
| Indicator | ELOX | MOBX |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 42.24 |
| Support Level | $15.21 | $1.03 |
| Resistance Level | $19.66 | $1.33 |
| Average True Range (ATR) | 2.75 | 0.15 |
| MACD | -0.29 | 0.02 |
| Stochastic Oscillator | 26.79 | 32.35 |
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.